Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod-Reference-Cited by-同舟云学术

Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod

Published:2018-06-13 Issue:10 Volume:24 Page:984-986
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neurosci Ther

Author:

Evangelopoulos Maria Eleftheria¹²,Miclea Andrei²^ORCID,Schrewe Lisa²,Briner Myriam²,Salmen Anke²^ORCID,Engelhardt Britta³,Huwiler Andrea⁴,Chan Andrew²,Hoepner Robert²^ORCID

Affiliation:

1. Department of Neurology; Eginition University Hospital; National and Kapodistrian University of Athens; Athens Greece

2. Department of Neurology; Bern University Hospital and University of Bern; Switzerland

3. Theodor Kocher Institute; University of Bern; Bern Switzerland

4. Institute of Pharmacology; University of Bern; Bern Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cns.12992/fullpdf

Reference7 articles.

1. Rebound Syndrome in patients with multiple sclerosis after cessation of fingolimod treatment;Hatcher;JAMA Neurol,2016

2. Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis;Gündüz;Mult Scler Relat Disord,2017

3. Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound;Cavone;Brain Behav Immun,2015

4. The sphingoinse 1-phosphate receptor modulator Fingolimod as a therapeutic agent: recent findings and new perspectives;Huwiler;Pharmacol Ther,2018

5. Clinical pharmacokinetics of fingolimod;David;Clin Pharmacokinet,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy;Clinical and Translational Neuroscience;2024-08-01

2. Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis;Neurology Clinical Practice;2024-04

3. Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice;International Immunopharmacology;2023-12

4. Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment;Multiple Sclerosis and Related Disorders;2023-11

5. Radiological abnormalities in progressive multifocal leukoencephalopathy: Identifying typical and atypical imaging patterns for early diagnosis and differential considerations;Multiple Sclerosis and Related Disorders;2023-09